Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 47, 4, (849-859), 10.1007/s00259-019-04555-6)

E. J. van Helden, S. G. Elias, S. L. Gerritse, S. C. van Es, E. Boon, M. C. Huisman, N. C.T. van Grieken, H. Dekker, G. A.M.S. van Dongen, D. J. Vugts, R. Boellaard, C. M.L. van Herpen, E. G.E. de Vries, W. J.G. Oyen, A. H. Brouwers, H. M.W. Verheul, O. S. Hoekstra, C. W.Menke van der Houven van Oordt*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

The Electronic Supplementary Materials are missing in the original article. Kindly check the Electronic Supplementary Materials in this article. The Publisher regrets this error. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Original languageEnglish
Number of pages1
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume47
Issue number10
DOIs
Publication statusAccepted/In press - 1 Jan 2020

Cite this